We studied the effect of MgADP on the mechanical interaction of actomyosin in cardiac and skeletal muscles using an in vitro motility assay. The sliding velocities of fluorescently labeled actin filaments on rat cardiac and skeletal myosins were measured at various MgATP and MgADP concentrations. The filament velocity depended on MgATP concentration according to classic Michaelis-Menten kinetics with apparent Michaelis constants (Ki) of 43 and 137 ,umol/L and maximum velocity of 5.6 and 8.6 ,um/s for cardiac and skeletal myosins, respectively. The presence of 2 mmol/L MgADP decreased the filament velocity and shifted the substrate concentration dependence of the velocity toward higher MgATP concentrations, yielding the inhibition constants of 194 and 478 gumol/L for cardiac and skeletal myosins, respec-
tively. The activation energies determined by the temperature dependence of the velocity were 61 and 83 kJ/mol for rat Vl and rabbit cardiac myosins, which were similar to those of the dissociation rate constant of actomyosin-ADP complex reported in a solution study. The inhibition of the velocity by MgADP can be explained by the crossbridge scheme in which MgADP competes with MgATP for the substrate site on myosin molecules. In cardiac myosin, addition of a concentration of MgADP as low as 25 ,umol/L significantly inhibited the velocity in the presence of 2 mmol/L MgATP, suggesting that increased intracellular MgADP may reduce the rate of crossbridge detachment, resulting in a decreased ATP consumption and an increased economy of force production under ischemic conditions. The present results support the idea that MgADP may be a physiologically important modulator of contraction in cardiac muscle. (Circ Res. 1994; 74:1027 -1033 Key Words * myocardial ischemia * ADP * motility * myosin isozyme It is generally believed that in shortening muscle, crossbridges formed between myosin on thick filaments and actin on thin filaments associate and dissociate cyclically, resulting in the relative sliding of thick and thin filaments and muscle contraction.1-3 This mechanical interaction of actin and myosin is believed to be coupled with hydrolysis of ATP to ADP and inorganic phosphate (Pi). Kinetics of the ATPase reaction have been investigated with intact myosin or its proteolytic products based on the assumption that the actomyosin ATPase reaction in solution resembles the in vivo ATP hydrolysis during muscle shortening. Earlier studies suggested that in contracting muscle, the products of ATP hydrolysis are released when myosin is attached to actin during the power stroke portion of the cycle.1-3 A condensed model of the ATPase cycle consistent with the recent solution studies is shown in Fig 1. According to this scheme, an increase in hydrolytic products such as ADP and Pi is expected to inhibit the transition in which they are released and thereby influence the power stroke. Earlier studies with skeletal muscle fibers revealed that elevated concentrations of MgADP increased isometric tension and decreased the maximum velocity of isotonic contraction, while addition of Pi decreased isometric tension without significant effect on the velocity.4-7 Although in fatigued skeletal muscles the intracellular concentration of MgADP might increase more than 10-fold over resting level, its effect on either tension or shortening velocity appeared to be rather small.46 However, recently some researchers reported that the intracellular concentration of MgADP could rise high enough to inhibit the rate of ATP hydrolysis in frog skeletal muscles and that the increase in the economy of force production observed in fatigued muscles might be explained by the accumulation of MgADP.8 The changes in the intracellular milieu of cardiac muscle under hypoxia were reported to be similar to those of fatigued skeletal muscle.6,9"10 In cardiac muscle, however, the effect of increased intracellular concentration of MgADP on actomyosin interaction under hypoxic conditions still remains controversial.6"11 Severe hypoxia or anoxia depressed contractile function, with a concomitant decrease in high-energy phosphate (ATP and creatine phosphate) concentration and an increase in tissue ADP concentration.910"12 Drew et all" reported that in solution, ADP inhibited the actin-activated ATPase activity of cardiac myosin subfragment-1 (S-i) to a much greater extent than it did skeletal myosin S-1 and suggested that ADP might be a physiologically important modulator of contractile function in cardiac muscle.
The purpose of this study was to investigate the effect of MgADP on the mechanical interaction of crossbridges, clarify the functional differences between cardiac and skeletal myosins under conditions that mim- icked ischemia, and further characterize the effect of MgADP in the current crossbridge kinetics. We used an in vitro motility assay in which fluorescently labeled actin filaments were made to move on a myosin layer fixed on a glass coverslip. '3-16 In this system, the relative sliding of actin and myosin is visualized as smooth movement of fluorescent actin filaments under a photomicroscope, and their velocity serves as a reliable index of mechanical sliding movement of actomyosin under zero load. Addition of 25 gtmol/L or more of MgADP in the presence of 2 mmol/L MgATP inhibited the filament velocity significantly, indicating that MgADP could affect the mechanical interaction of actomyosin in cardiac muscle, since the intracellular concentration of MgADP under hypoxic or anoxic conditions is within this range (54 to 700 ,amol/L).9Y""",2 The inhibitory effect of MgADP on the sliding movement of actomyosin observed in vitro suggests that the accumulation of ADP under ischemic conditions may protect myocardium from contractile failure and irreversible damage by preventing rapid ATP depletion and increasing the economy of force production in vivo. The apparent inhibition constant (K,) for MgADP determined on the filament velocity was smaller in cardiac myosin than in skeletal myosin (194 versus 478 gmol/L). The pronounced inhibitory effect of MgADP observed in cardiac myosin may be physiologically adaptive, since cardiac muscle continues cyclic contraction under various loading conditions with limited capacity of oxygen supply. The temperature dependence of the filament velocity was similar to that of the dissociation rate constant of actomyosin-ADP complex reported in a solution study,17 suggesting that the ADP dissociation step in the scheme may limit the filament velocity. The present results support the idea that MgADP may inhibit the mechanical interaction of actomyosin by competing with MgATP for the active site on the myosin molecule and slowing crossbridge detachment by MgATP.
Materials and Methods

Protein Preparation
Cardiac myosin was prepared from rats and rabbits. Vl myosin was obtained from 3-week-old male Wistar rats.'8 V3 myosin was obtained from 12-week-old male Wistar rats treated with 0.7 mg/mL methimazole (Chugai Pharmaceutical Co) in drinking water for 12 weeks.'s Skeletal myosin was prepared from adult rat leg muscles. Animals were anesthetized with diethylether, and the hearts were excised rapidly. All procedures described below were performed at 4°C. The hearts were washed with buffered saline ( mmol/L tris-HCI, 5 mmol/L DTT, pH 7.5), and the trace amount of actin was removed by centrifugation (65P, Hitachi) at 120 000g for 4 hours. Skeletal myosin was purified in the same way as cardiac myosin. Protein concentration was determined by the method of Lowry et al. 9 The homogeneity of Vl and V3 isomyosin preparations was confirmed by the pyrophosphate gel electrophoresis method described by Hoh et a120 ( Fig 2) . This myosin solution was stored in an ice-cooled container and used for the in vitro motility assay within 48 hours after purification. Actin was prepared from rabbit back muscle acetone powder by the method of Spudich and Watt.2'
In Vitro Motility Assay We used the method described by Kron lens (NA 1.3, Zeiss), a 100-W super-high-pressure mercury lamp, and a rhodamine filter set (Fig 3) . The fluorescent images of the filaments were displayed on a TV monitor (C1846-03, Hamamatsu-Photonics) with a highly sensitive silicon intensifier target (SIT) camera (C2400, Hamamatsu-Photonics) and a video timer (VTG-33, FOR-A Co) and recorded with a video recorder (BR-S601M, JVC) on videotapes. Except when the effect of temperature was studied, all experiments were performed at 30°C with a water-jacketed slide carrier and objective heater.
Velocity Measurement
The velocity of the filaments was measured by replay of the videotapes. The position of the leading end of each filament was transferred onto a clear film from the monitor screen, and displacement of each filament was measured by the digitizer. Although some of the moving filaments suddenly stopped and then resumed moving at the same velocity as before, the fraction of actin filaments moving was more than 95% (Fig 3) .
The velocity was calculated from the displacement and the elapsed time recorded by the video timer. To reduce quantification errors, only continuous movements for >3 seconds or >5 gm were scored. The mean velocity was calculated from 20 to 30 different filaments. To study the determinants of the velocity, the experiments were performed under the following protocols.
Effects of Nucleotide Concentration
The filament velocity was measured under various MgATP concentrations between 0 and 2 mmol/L both in the presence (2 mmol/L) and in the absence of MgADP. Then the experiments were repeated under various MgADP concentrations between 0 and 2 mmol/L while MgATP concentration was fixed at 2 mmol/L. In this experimental protocol, rat cardiac Vl and skeletal myosins were used.
Effect of Temperature
The velocity was measured at different temperatures from 19°C to 33°C for rat Vi and V3 myosins and from 19°C to 29°C for rabbit cardiac myosin. The temperature was precisely controlled by an electric thermometer (MGA 111-219, Nihon Koden) and thermistor (Type PT, Shibaura Electronics). Statistical Analysis Data were indicated as mean±SD. The correlation between the parameters was studied by linear regression analysis. A value of P<.05 was considered to be significant.
Results
Effects of Nucleotide Concentration
The filament velocity was dependent on the MgATP concentration; ie, the velocity increased with an increase in MgATP concentration both in the presence and in the absence of MgADP (Fig 4) . However, the velocities were lower in the presence of 2 mmol/L MgADP than in the absence of MgADP at all MgATP concentrations examined (P<.01). The velocity was also dependent on MgADP concentration; ie, the velocity decreased significantly with an increase in MgADP concentration at a constant MgATP concentration in cardiac myosin ( Fig 5) . The effect of MgADP on the velocity was opposite to that of MgATP. In Fig 6, the ratio of the velocity measured at a given temperature over that measured at a temperature 10°C lower) was lower for myosin with higher sliding velocity (2.3 for rat Vi, 2.7 for rat V3, and 3.1 for rabbit), indicating that myosin with higher velocity showed less temperature dependence than that with lower velocity. Linear regression analysis on the Arrhenius plots of these data yielded the activation energies of 61, 74, and 83 kJ/mol for rat VI, rat V3, and rabbit myosins, respectively. Discussion In the present study, we measured the sliding velocity of actin filaments on cardiac and skeletal myosins using an in vitro motility assay system. The velocity was dependent on MgATP concentration and followed classic michaelian behavior as a function of MgATP concentration. Addition of MgADP depressed the velocity and shifted the substrate concentration dependence of the velocity toward higher concentrations in both cardiac and skeletal myosins. The observation that MgADP had an inhibitory effect on the filament velocity indicated that MgADP could affect the mechanical interaction of actomyosin in muscle shortening. The inhibition of the filament velocity by MgADP was greater in cardiac myosin than in skeletal myosin. The temperature dependence of the filament velocity was similar to that of the dissociation rate constant of actomyosin-ADP complex reported in a solution study.17 These results suggest that the maximum rate of mechanical sliding of actomyosin may be limited by the rate of ADP dissociation from actomyosin in the crossbridge scheme and that MgADP may inhibit the mechanical interaction of actomyosin by competing with MgATP for the active site on myosin molecules and thereby slowing crossbridge detachment by MgATP.
In Vitro Motility Assay
We applied an in vitro motility assay technique developed by Kron and Spudich" with some modifications.14 In this system, fluorescently labeled actin filaments were made to slide on a myosin layer adhering to a glass coverslip. Earlier studies on various types of myosins demonstrated that it is a good model system for muscle contraction and reliable as a quantitative assay for mechanical interaction of actomyosin.13"'56 Since the viscous force imposed on a moving actin filament is negligible, the filament velocity is expected to be limited by crossbridge kinetics and is thus a good indicator of the maximum rate of relative sliding movement of actin and myosin under unloaded conditions. Since the selection of moving filaments for analysis significantly influenced the determination of filament velocity as well as the derived values (eg, Kin, Qrn),16 we used the criteria described in "Materials and Methods" in selecting filaments to be scored. Both the high fraction of moving filaments observed in the present experiments (>95%) and scoring of the same number of filaments moving continuously for a given time interval (>3 seconds) or distance (>5 ,m) in each experiment enabled us to reduce the confounding effects of discontinuous movement of the filaments and obtain reproducible results. Although it may be difficult in some cases to compare the present results with those from other laboratories because of different preparations and/or assay conditions, the present study allows differences between cardiac and skeletal myosins to be determined under identical experimental conditions.
Effect of ATP on Velocity
The filament velocity was dependent on MgATP concentration. Assuming that the filament velocity follows classic michaelian behavior with MgATP as a substrate, the apparent Km are 43 and 137 ,umol/L for cardiac Vl and skeletal myosins, respectively. These values are more than one order of magnitude higher than those for actin-activated ATPase activity in solution (1 and 4 ,umol/L for cardiac" and skeletal22 myo- sins, respectively). One possible explanation for the difference in apparent Km values of the actin-activated ATPase activity in solution and the filament velocity is that the rate-limiting step for mechanical sliding of actin filaments on myosin may differ from that for steadystate ATP hydrolysis by actomyosin in solution.3'17'23 This possibility will be discussed later. Another possible explanation may be the existence of mechanical interactions among crossbridges in the in vitro motility assay; ie, under low MgATP concentrations, the presence of rigorlike crossbridges without ATP molecules in their active sites may impose an internal load on cycling crossbridges to reduce the filament velocity disproportionately.13,15'22 Conversely, in solution, the overall rate of ATP hydrolysis may not be affected by the rigorlike bridges because each molecule can act independently.
In our previous study with another type of in vitro motility assay, in which myosin-coated beads were made to slide on algal actin cables, Km for half maximum velocity of beads coated with rabbit cardiac myosin was 25 to 40 ,mol/L, similar to that with rat cardiac myosin in the present study.24'25 The present Km value for skeletal myosin is in good agreement with that for shortening velocity of rabbit skeletal fibers (150 ,umol/ L).4 It is somewhat higher than those for rabbit skeletal myosin reported in the previous studies with similar assay systems (50,13 88,16 and around 60 ,mol/L22). The small differences among these studies may be explained by the differences in the skeletal muscle types (predominantly white or mixture of red and white muscles), myosin preparations (intact monomeric myosin, filamentous myosin, or heavy meromyosin), and/or the assay conditions (eg, ionic strength, pH, temperature, and the presence of ATP backup system). If we assume that the filament velocity is determined by the balance between resistant force of rigor crossbridges and propulsive force of working ones22 and that the resistant force per rigor bridge is the same between cardiac and skeletal myosins, the lower Km value observed in cardiac myosin suggests that the ratio of the number of working crossbridges to that of rigor crossbridges may be greater in cardiac myosin than in skeletal myosin at low MgATP concentrations, because the average propulsive force per crossbridge of cardiac Vl myosin is estimated to be smaller than that of skeletal myosin.26 Since cardiac muscle must continue contraction and relaxation cycles to pump out blood continuously, the smaller fraction of rigor crossbridges formed at low MgATP concentrations may be physiologically adaptive, especially under ischemic conditions.
Effect of ADP on Velocity
The addition of MgADP shifted the substrate dependence of the velocity toward higher MgATP concentrations in both cardiac and skeletal myosins (Fig 4) . If we assume that the inhibition of velocity by MgADP follows the behavior of enzymatic reaction, the apparent Km in the presence of 2 mmol/L of MgADP (Kmi) increases by 11 (cardiac myosin) and 5 (skeletal myosin) times, with smaller or no changes in the maximum velocity at infinite substrate concentration. These results suggest that MgADP may act primarily as a competitive inhibitor of mechanical interaction of actomyosin and are consistent with the observations in rabbit skeletal actomyosin S-1 ATPase activity in solution,2728 rabbit skeletal fibers,4'29 and the filament velocity in similar assay systems.15'16
Temperature Dependence of Velocity
In the present study, cardiac myosin with higher velocity was less dependent on temperature than that with lower velocity. The temperature coefficient (Q1o) was lowest in rat Vi myosin (2.3) and highest in rabbit cardiac myosin (3.1), and these values were close to Q1o values for maximum shortening velocity of papillary muscles (1.9 for rabbit,30 1.9 for rabbit and marmot,31 2.5 for cat32). The activation energies for the molecular step limiting the filament velocity were calculated from the slopes of the Arrhenius plots and were higher in rat V3 myosin (74 kJ/mol) than in Vi myosin (61 kJ/mol).
The present results were consistent with the observation that the activation energies of the maximum rate of tension rise and the rate constant of exponential rise of tension, both of which had temperature dependence similar to maximum shortening velocity, were higher for slow-twitch skeletal muscles than fast-twitch ones. 23 It is generally accepted that the maximum shortening velocity of muscle correlates with the steady-state rate of ATP hydrolysis by actomyosin in various types of muscles.33 However, it still remains controversial whether the rate of ATP hydrolysis directly limits the shortening velocity; in other words, whether the maximum rate of muscle shortening in vivo and the rate of ATP hydrolysis by actomyosin in vitro are limited by the same molecular step.17'23'33'34 Siemankowski et a117 reported that the ADP dissociation step could limit shortening velocity in vertebrate muscles and not limit the steady-state rate of ATP hydrolysis in solution.
Conversely, de Tombe and ter Keurs34 suggested that the same molecular step might limit the rate of ATP hydrolysis by actomyosin in both solution and shortening muscle under zero load. If we assume that the same molecular step may limit the rate of both mechanical interaction and steady-state ATP hydrolysis by actomyosin, the temperature dependence of these parameters should be identical. In the present study, the activation energies for velocity were considerably smaller than those of the maximum rate of steady-state ATP hydrolysis (122 and 105 kJ/mol for rat and rabbit cardiac actomyosin S-1, respectively) but close to those of the rate constant of ADP dissociation from actomyosin S-1-ADP complex in solution reported by Siemankowski et al17 (64 and 76 kJ/mol for rat and rabbit cardiac actomyosin S-1, respectively). These results suggest that the rate of mechanical sliding of actomyosin may be limited by the ADP dissociation step from the actomyosin-ADP complex, whereas the maximum rate of steady-state ATP hydrolysis by actomyosin in solution may be limited by a different step in the kinetic model.17'23 Therefore, the difference between the apparent Km value of the actin-activated ATPase activity in solution and that of filament velocity observed in the present study may be partly explained by this difference in their rate-limiting steps.
Crossbridge Scheme
The competitive inhibition of the velocity by MgADP was consistent with the observations in skinned fi-bers4"5'29'35'36 and ATPase activity in solution.1"'27 '28 These results support the idea that MgADP may compete with MgATP for the substrate site on myosin and inhibit crossbridge detachment by MgATP, because the filament velocity may be kinetically limited by the ADP dissociation step (Fig 7) . If we assume that the inhibition of the velocity by MgADP follows the behavior of a competitive enzyme inhibitor, the inhibition constants In the present study, a linear regression analysis was applied to the Lineweaver-Burk plots of the relation between the velocity and MgATP concentration assuming Michaelis-Menten kinetics. However, the present data on cardiac myosin might be better fit with a concave downward curve ( Fig 6A) . The curvature could also be explained by the model in which MgADP competes for the ATP-binding site on the myosin molecule.3536 At ATP concentrations sufficiently high to make both ATP binding to actomyosin and subsequent dissociation of myosin from actin fast, the filament velocity will be limited by the rate of dissociation of ADP from the actomyosin-ADP complex. At low ATP concentrations, however, the presence of MgADP may impose a preequilibrium step that decreases the fraction of actomyosin to bind ATP and reduce the velocity in a manner different from a pure competitive inhibitor. According to Siemankowski and White,35 the apparent rate of dissociation of actomyosin-ADP by MgATP was inhibited by MgADP noncompetitively under these limiting conditions. Therefore, the concave-downward curvature observed in cardiac myosin might be explained by a competitive inhibition of the velocity by MgADP at higher MgATP concentrations and a noncompetitive inhibition at lower MgATP concentrations. In the present results on cardiac myosin, a linear regression analysis from data at higher MgATP concentrations (0.5 mmol/L or more) will give a higher maximum velocity at infinite substrate concentration (5.6 ,um/s) similar to that obtained in the absence of MgADP. Another possible explanation for this curvature may be the mechanical interaction of crossbridges: addition of MgADP may increase the proportion of the actomyosin-ADP state, which is supposed to be a strong binding and principal force-producing state in the crossbridge model, and thus produce a resistive force to retard the filament velocity disproportionately, as the formation of rigor crossbridges may inhibit the velocity under low MgATP concentrations.15 However, this type of curvilinear relation in the Lineweaver-Burk plots was not observed in skeletal myosin ( Fig 6B) . Further studies will be required to investigate the causes of the different mechanical function of molecules at low MgATP concentrations between cardiac and skeletal myosins. Physiological Significance of MgADP Inhibition 31P nuclear magnetic resonance studies have revealed that under hypoxic or anoxic conditions, the products of ATP hydrolysis (ADP and Pi) accumulate in cardiac tissues.1012 The intracellular concentration of MgADP has been reported to increase by 2 to 20 times, with a concomitant decrease in concentrations of MgATP and creatine phosphate.9"10"12 The estimated intracellular concentration of ADP varied widely depending on experimental preparations or conditions: 180 ,umol/L in isolated ferret heart under metabolic inhibition,10 700 ,umol/L in isolated rat heart after 2 minutes of anoxia,9 and 54 ,mol/L in living rat heart under hypoxic ventilation.'2 However, the local concentration of MgADP in the vicinity of the crossbridges may be still higher than these estimations because of compartmentalization,12 restricted space for MgADP diffusion in the filament overlap zone, and limited buffering capacity of MgADP by the phosphocreatine circuit.8 In cardiac myosin, addition of a concentration of MgADP as low as 25 1Tmol/L inhibits the filament velocity significantly in the presence of 2 mmol/L MgATP (Fig 5) , which strongly suggests that the increased intracellular concentration of MgADP under hypoxic conditions can affect the mechanochemical interaction of actomyosin in vivo.
Since the tension cost (ATPase activity/developed force) in muscle contraction is believed to be proportional to the crossbridge detachment rate,37 the inhibition of crossbridge dissociation by MgADP may play a modulatory role by reducing ATP hydrolysis rate and increasing the economy of force production. It might also be involved in the impaired diastolic relaxation observed in myocardial ischemia38 by increasing the proportion of actomyosin-ADP complex, which is supposed to be a strong binding state. The pronounced inhibition of the filament velocity by MgADP observed in cardiac myosin may be adaptive in that the accumulation of MgADP under myocardial ischemia may provide a negative feedback to slow oxygen consumption and protect myocardium from irreversible damage.
Since the intracellular concentration of MgADP is known to be determined primarily by the phosphocreatine circuit, both the concentration of creatine phosphate and the activity of creatine phosphokinase may also play an important role in modulating the contractile state and economy of muscle shortening.
In summary, addition of MgADP decreased the velocity of actin filaments on both cardiac and skeletal myosins in the in vitro motility assay system. The inhibition of the velocity by MgADP can be explained by a crossbridge model in which MgADP competes with MgATP for the substrate site on myosin. The present results support the idea that MgADP may be a physiologically significant modulator of muscle contraction, acting as a competitive inhibitor of crossbridge detachment.
